Cargando…

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krenn-Pilko, S, Langsenlehner, U, Thurner, E-M, Stojakovic, T, Pichler, M, Gerger, A, Kapp, K S, Langsenlehner, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021515/ https://www.ncbi.nlm.nih.gov/pubmed/24675383 http://dx.doi.org/10.1038/bjc.2014.163

Ejemplares similares

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
por: Troppan, K, et al.
Publicado: (2014)

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
por: Stotz, M, et al.
Publicado: (2013)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
por: Pichler, M, et al.
Publicado: (2013)

Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
por: Cummings, M, et al.
Publicado: (2015)

BCL2 genotypes and prostate cancer survival
por: Renner, Wilfried, et al.
Publicado: (2017)

Reply: Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
por: Szkandera, J, et al.
Publicado: (2013)

Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
por: Dalpiaz, O, et al.
Publicado: (2014)

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
por: Dalpiaz, Orietta, et al.
Publicado: (2017)

Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
por: Aigelsreiter, A, et al.
Publicado: (2013)

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
por: Partl, Richard, et al.
Publicado: (2020)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer
por: Ishizuka, M, et al.
Publicado: (2013)

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014)

Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
por: Pichler, M, et al.
Publicado: (2012)

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
por: Pichler, M, et al.
Publicado: (2014)

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer
por: Frietsch, J J, et al.
Publicado: (2010)

Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor
por: Chang, Wei-Long, et al.
Publicado: (2020)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
por: Meniawy, T M, et al.
Publicado: (2013)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
por: Proctor, M J, et al.
Publicado: (2012)

The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer
por: Partl, Richard, et al.
Publicado: (2023)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
por: Chua, W, et al.
Publicado: (2011)

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
por: Arrieta, O, et al.
Publicado: (2008)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
por: Turato, C, et al.
Publicado: (2014)

The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy
por: Delago, Daniela, et al.
Publicado: (2020)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma
por: Trietsch, M D, et al.
Publicado: (2013)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016)

Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas
por: Bäcklund, L M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_pcve22doan7i1bkfbh8tphfano